Abstract

“Harm reduction” programs, including needle exchange, have lowered rates of new HIV infection among drug users. However, rates of hepatitis C virus (HCV) infection remain high, and, in fact, intravenous drug use is considered to be the prime engine driving this persistent infection in the …

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.